Mylan Labs Board Rebuffs Icahn Pitch
639924
Mylan Laboratories Inc.'s  board on Monday rebuffed financier Carl Icahn's bid to buy the company, and said it remains committed to its &#36;3.37 billion purchase of brand-name drug-maker King Pharmaceuticals Inc. .
392324
IntercontinentalExchange Inc.  on Thursday urged CBOT Holdings Inc.  shareholders and members to reject the proposed sale of the company to Chicago Mercantile Exchange Holdings Inc.
146318
PITTSBURGH, Dec. 20 /PRNewswire-FirstCall/ -- Mylan Laboratories Inc. (NYSE:MYL) announced today that the regular quarterly cash dividend of $.03 per share will be payable on January 14, 2005, to shareholders
378950
NEW YORK/BOSTON  - Activist investor Carl Icahn threatened on Friday to launch a proxy battle for control of BEA Systems Inc  if the software maker does not begin an auction process to sell itself.
580086
WASHINGTON (CBS.MW) -- Mylan Laboratories (MYL) , responding to the latest in a series of letters from investor Carl Icahn, reasserted its position that acquiring King Pharmaceuticals (KG) is in the long-term interest of the generic drugmaker and its
161270
Billionaire investor Carl Icahn said on   Thursday he is seeking approval from shareholders of ImClone   Systems Inc. IMCL.O to remove six directors from its board,   including the chairman and the interim chief executive, and   bring in one of his own nominees.
447547
IntercontinentalExchange Inc.  on Thursday urged Chicago Board of Trade  shareholders and members to reject the proposed sale to Chicago Mercantile Exchange Holdings Inc.
581364
Here&#39;s another one for the Best Poison Pen Letters of 2004 contest. Mylan Laboratories (nyse: MYL - news - people ) Chairman Milan Puskar says Carl Icahn &quot;miscalculated&quot; with his threats to block Mylan&#39;s merger
404301
Mylan Laboratories Inc., the largest US maker of generic drugs, cautioned investors Friday that Thursday&#39;s jump in share price was likely driven by investor Carl Icahn&#39;s clearance to buy a large amount of company stock and fails to reflect &quot;negative ...
15173
Reckson Associates Realty Corp.  said on Monday it would postpone a shareholder meeting until December 6 to give billionaire Carl Icahn and his partners more time to firm up financing for their $4.6 billion bid for the company.
741365
PITTSBURGH Mylan Laboratories again reiterated its commitment to the estimated four (B) billion dollar acquisition of brand-name drug maker King Pharmaceuticals despite Wall Street financier Carl Icahn upping his stake in the company.
271608
SL Green Realty said it would not raise its offer for Reckson Associates Realty to match a competing bid by a group led by the financier Carl C. Icahn.
282450
Mylan Laboratories Inc., the biggest US maker of generic drugs, received a $20-a-share bid from Carl Icahn, the company&#39;s largest investor and a critic of Mylan&#39;s plan to buy King Pharmaceuticals Inc.
434653
WILMINGTON, Del. -- Shareholders of auto supplier Lear Corp. rejected a $2.9 billion buyout offer Monday from a firm led by billionaire investor Carl Icahn.
191627
Check--or checkmate? Carl Icahn, attempting to block Mylan Laboratories (nyse: MYL - news - people ) in its buyup of King Pharmaceuticals (nyse: KG - news - people ), made his move: Earlier this month, the
603432
PITTSBURGH The chief executive of Mylan Laboratories says a move by Wall Street financier Carl Icahn (EYE&#39;-kahn) to halt Mylan&#39;s acquisition of King Pharmaceuticals is wrongheaded.
386076
In a letter to the board of directors at Mylan Laboratories (nyse: MYL - news - people ), financier Carl Icahn questioned their silence on the recent financial restatements by King Pharmaceuticals (nyse: KG - news - people ), calling the &quot;lack of